Search Results - David Y Oh

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Combination immunotherapy induces distinct T-cell repertoire responses when administered to patients with different malignancies by Li Zhang, Lawrence Fong, Jason Cham, Serena Kwek, Alan Paciorek, Tao He, Grant Fong, David Y Oh

    Published in Journal for ImmunoTherapy of Cancer (2020-05-01)
    Get full text
    Article


  2. 2

    Identification and regulation of circulating tumor-TCR-matched cytotoxic CD4+ lymphocytes by KLRG1 in bladder cancer by Serena S. Kwek, Hai Yang, Tony Li, Arielle Ilano, Eric D. Chow, Li Zhang, Hewitt Chang, Diamond Luong, Averey Lea, Matthew Clark, Alec Starzinski, Yimin Shi, Elizabeth McCarthy, Sima Porten, Maxwell V. Meng, Chun Jimmie Ye, Lawrence Fong, David Y. Oh

    Published in JCI Insight (2025-06-01)
    Get full text
    Article


  3. 3

    862 TLR9 agonism promotes cytotoxic T cell persistence and myeloid remodeling when combined with radiation therapy and PD-1 blockade in oligometastatic prostate cancer patients by Li Zhang, Lawrence Fong, David Y Oh, Eliezer Van Allen, Felix Y Feng, Anthony Wong, Eric J Small, Terence W Friedlander, Alec Starzinski, Zenghua Fan, Tony Li, Hewitt Chang, Marissa Gin, Katsuto Shinohara, Hao Nguyen, Caleb Hwang, Christopher De Leon, Rahul R Aggarwal

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  4. 4

    Dysregulation of CD4+ and CD8+ resident memory T, myeloid, and stromal cells in steroid-experienced, checkpoint inhibitor colitis by Li Zhang, Lawrence Fong, Brittany Davidson, David Y Oh, Frances Fan, Alexander Cheung, Hai Yang, Jun Yan He, Yang-Joon Kim, Elvira Mennillo, Iulia Rusu, Jared Bain, Arjun A Rao, Christopher Andersen, Karen Law, Jessica Tsui, Alan Shen, Divyashree Kushnoor, Yimin Shi, Alexis J Combes, Angela O Pisco, Michael G Kattah

    Published in Journal for ImmunoTherapy of Cancer (2024-04-01)
    Get full text
    Article


  5. 5

    TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor by Li Zhang, Divya Natesan, Lawrence Fong, Emily Chan, David Y Oh, Son Ho, Ivan de Kouchkovsky, Errol J Philip, Francis Wright, Daniel M Kim, Daniel Kwon, Hansen Ho, Sima P Porten, Anthony C Wong, Arpita Desai, Franklin W Huang, Jonathan Chou, Raj S Pruthi, Eric J Small, Terence W Friedlander, Vadim S Koshkin

    Published in Journal for ImmunoTherapy of Cancer (2021-05-01)
    Get full text
    Article


  6. 6

    Single-cell and spatial multi-omics highlight effects of anti-integrin therapy across cellular compartments in ulcerative colitis by Elvira Mennillo, Yang Joon Kim, Gyehyun Lee, Iulia Rusu, Ravi K. Patel, Leah C. Dorman, Emily Flynn, Stephanie Li, Jared L. Bain, Christopher Andersen, Arjun Rao, Stanley Tamaki, Jessica Tsui, Alan Shen, Madison L. Lotstein, Maha Rahim, Mohammad Naser, Faviola Bernard-Vazquez, Walter Eckalbar, Soo-jin Cho, Kendall Beck, Najwa El-Nachef, Sara Lewin, Daniel R. Selvig, Jonathan P. Terdiman, Uma Mahadevan, David Y. Oh, Gabriela K. Fragiadakis, Angela Pisco, Alexis J. Combes, Michael G. Kattah

    Published in Nature Communications (2024-02-01)
    Get full text
    Article


Search Tools: